Lalle, E.; Mazzotta, V.; Sberna, G.; Fabeni, L.; Garbuglia, A.R.; Mastrorosa, I.; D’Abramo, A.; Nicastri, E.; Girardi, E.; Antinori, A.;
et al. Saliva Is a Sensitive and Accessible Sample Both for SARS-CoV-2 Detection and for the Evaluation of Treatment Effectiveness in Follow-Up Studies. Viruses 2024, 16, 1040.
https://doi.org/10.3390/v16071040
AMA Style
Lalle E, Mazzotta V, Sberna G, Fabeni L, Garbuglia AR, Mastrorosa I, D’Abramo A, Nicastri E, Girardi E, Antinori A,
et al. Saliva Is a Sensitive and Accessible Sample Both for SARS-CoV-2 Detection and for the Evaluation of Treatment Effectiveness in Follow-Up Studies. Viruses. 2024; 16(7):1040.
https://doi.org/10.3390/v16071040
Chicago/Turabian Style
Lalle, Eleonora, Valentina Mazzotta, Giuseppe Sberna, Lavinia Fabeni, Anna Rosa Garbuglia, Ilaria Mastrorosa, Alessandra D’Abramo, Emanuele Nicastri, Enrico Girardi, Andrea Antinori,
and et al. 2024. "Saliva Is a Sensitive and Accessible Sample Both for SARS-CoV-2 Detection and for the Evaluation of Treatment Effectiveness in Follow-Up Studies" Viruses 16, no. 7: 1040.
https://doi.org/10.3390/v16071040
APA Style
Lalle, E., Mazzotta, V., Sberna, G., Fabeni, L., Garbuglia, A. R., Mastrorosa, I., D’Abramo, A., Nicastri, E., Girardi, E., Antinori, A., Maggi, F., & Bordi, L.
(2024). Saliva Is a Sensitive and Accessible Sample Both for SARS-CoV-2 Detection and for the Evaluation of Treatment Effectiveness in Follow-Up Studies. Viruses, 16(7), 1040.
https://doi.org/10.3390/v16071040
